CClinicalTrials.gg
TerminatedNCT00958139Updated Jun 4, 2020

Passive Prophylaxis of Lyme Disease Using Permethrin Treated Clothes

A Phase 3 interventional study of Permethrin and Placebo in Lyme Disease, sponsored by University of Minnesota. Terminated at 1 site in United States. Open to participants aged 14 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2020-06-04.

Sponsored by University of Minnesota · Phase 3, Interventional, and Prevention

Why this study was terminated
After year 1, there was insufficient statistical power to detect a difference in the primary outcome measure during planned study period.
Phase
Phase 3
Study type
Interventional
Enrollment
61
Allocation
Randomized
Ages
14 Years to 65 Years
Sex
All
01

Study summary

Hypothesis: Does treatment of lower extremity clothing with permethrin prevent Lyme disease?

This is a double-blind, randomized clinical trial using permethrin treatment of clothing to prevent Lyme disease.

Read the detailed description

This is a double-blind, randomized clinical trial using permethrin treatment of clothing to prevent Lyme disease.

Subjects (N=200) will be recruited from camp staff to participate in the study and screened by inclusion and exclusion criteria.Qualifying subjects will be randomized to either the treatment (N=100) or non-treatment arm (N=100).

Subjects in the treatment arm will have their scout shorts, pants, and socks sprayed with 0.5% permethrin and allowed to dry. Subjects in the non-treatment arm will have their scout shorts, pants, and socks sprayed with water and allowed to dry.

Subjects will then be followed over the summer camping season to see if they develop Lyme disease. At 70 days, all subjects will have their Lyme titers rechecked to ensure that all cases of Lyme disease were documented.

Following the 70 day visit, there will be an assessment of the final study outcomes.

02

Conditions studied

  • Lyme Disease

Browse trials for

Keywords

  • Lyme disease
  • tick
03

In context

Lyme Disease

91 studies on the registry are indexed under Lyme Disease; 27 are open to participants now.

This study's enrollment of 61 is below the median of 100 across 49 interventional studies indexed under Lyme Disease.

Browse Lyme Disease studies →

Lead sponsor

University of Minnesota is the lead sponsor of 1,184 studies on the registry; 195 are open to participants now.

Of its 132 completed or terminated interventional studies of FDA-regulated products, 91 (69%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
14 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Summer camp staff at Tomahawk Scout Reservation
  • Works in an outdoor environment
  • Sleeps in an outdoor environment (platform tent)
  • Present for the entire camp season (June - August)
  • Informed consent

Exclusion criteria

Exclusion Criteria:

  • Contraindication, allergy or previous reaction to permethrin
  • Inability of subject or surrogate (e.g., parent if \< 18 years of age) to provide informed consent
05

Study design

Phase
Phase 3
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Quadruple (Participant, Care provider, Investigator, Outcomes assessor)
Enrollment
61 participants (actual)

Study arms

  • Experimental
    Permethrin treatment of clothing

    0.5% permethrin sprayed one time on uniform shorts, pants, and socks

    Other: Permethrin

  • Sham comparator
    Placebo

    Water sprayed on uniform shorts, pants, and socks

    Other: Placebo

Interventions

  • OtherPermethrin

    Permethrin 0.5% treatment of clothing one time

  • OtherPlacebo

    water sprayed on clothing one time

06

What researchers measure

Primary outcomes

  1. Incidence of Lyme disease

    Time frame: Day <=70

07

Study locations

1 site
  • Tomahawk Scout Camp
    Rice Lake, Wisconsin, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 4, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00958139
Lead sponsor
University of Minnesota
Responsible party
Sponsor
First posted
Aug 13, 2009
Start date
Jun 2008
Primary completion
Aug 2008
Completion
Oct 2008
Last update
Jun 4, 2020

Study contacts

David R. Boulware, MD, MPH
principal investigator · University of Minnesota

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Jun 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion